ALAN JAN REIS
Medical Practice in Pittsburgh, PA

License number

Pennsylvania MD067424L

Personal information

See more information about ALAN JAN REIS at radaris.com

Name

Address

Phone

Alan Reis, age 68

524 4Th St, Monongahela, PA 15063

Alan J Reis

230 Craig St, Pittsburgh, PA 15213

(412) 682-3003
(412) 687-1751

Alan J Reis

524 4Th St, Monongahela, PA 15063

(724) 258-3373

Alan J Reis

524 4Th St, Monongahela, PA 15063

(724) 258-3373
(724) 258-2609

Alan J Reis, age 66

5107 Ellsworth Ave, Pittsburgh, PA 15232

(412) 605-0805

Professional information

See more information about ALAN JAN REIS at trustoria.com

Dr. Alan J Reis, Pittsburgh PA - MD (Doctor of Medicine)

Specialties:

Neuropsychiatry (Psychiatry)

Address:

Alan J Reis MD
540 N Neville St SUITE 104, Pittsburgh 15213
(412) 687-0700 (Phone)

Certifications:

Psychiatry, 2000

Awards:

Healthgrades Honor Roll

Languages:

English

Education:

Medical School
Rosalind Franklin University of Medicine and Science / Chicago Medical School
Graduated: 1995

Registry Method And Control System For Dea Schedule Ii-V Medicines

US Patent:

2009020, Aug 20, 2009

Filed:

Feb 23, 2006

Appl. No.:

11/922794

Inventors:

Alan J Reis - Pittsburgh PA, US
Christian Schafmeister - Pittsburgh PA, US

International Classification:

A61K 51/00, C07D 243/14, C07C 211/01, C07C 209/44, C07D 211/32, C07D 489/00, C07D 211/58, C07C 215/42, C07D 471/04, C12Q 1/02

US Classification:

424 181, 540570, 564374, 564375, 546248, 546 44, 564316, 546244, 564443, 546121, 435 29

Abstract:

The present invention provides compositions and methods for synthesizing labeled drugs. The present invention further provides methods for preventing or stopping prescription drug abuse for all agents registered as a Drug Enforcement Agency (DEA) schedule II through schedule V medications. According to the present invention, methods are provided for monitoring patient compliance with prescribed drug treatment. The present invention also provides methods for facilitating a replacement prescription when a patient is left without access to their prescribed drug. Furthermore, the present invention provides a method to improve employee compliance with an employer's drug policies via either a voluntary or compulsory system for enhanced drug testing.